Issue Date | Title | Author(s) | Relation | scopus | WOS | Fulltext/Archive link |
---|---|---|---|---|---|---|
2016 | Preclinical investigation of Ibrutinib, a Bruton’s kinase tyrosine (Btk) inhibitor, in suppressing glioma tumorigenesis and stem cell phenotypes | Wei, L; Su, YK; Lin, CM; Chao, TY; Huynh, TT; Jan, HJ; Whang-Peng, J; Chiou, JF; Wu, AT; Hsiao, M | Oncotarget 7(43), 69961-975 | |||
2018 | Serum amyloid A1 in combination with integrin αVβ3 increases glioblastoma cells mobility and progression | Lin, CY; Yang, ST; Shen, SC; Hsieh, YC; Hsu, FT; Chen, CY; Chiang, YH; Chuang, JY; Chen, KY; Hsu, TI; Leong, WC; Su, YK; Lo, WL; Yeh, YS; Patria, YN; Shih, HM ; Chang, CC; Chou, SY | Molecular Oncology 12(5), 756-771 | |||
2018 | The disruption of the β-Catenin/TCF-1/STAT3 signaling axis by 4-Acetylantroquinonol B inhibits the tumorigenesis and cancer stem-cell-like properties of glioblastoma cells, in vitro and in vivo | Liu, HW; Su, YK; Bamodu, OA; Hueng, DY; Lee, WH; Huang, CC; Deng, L; Hsiao, M; Chien, MH; Yeh, CT; Lin, CM | Cancers 10(12), 491 |